StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / tisentotx.com

Tisento Therapeutics

Tisento Therapeutics (tisentotx.com): no confident changes recorded yet; website history since November 2026. Homepage last checked 13 November 2026.

First recorded website

Observed 13 November 2026

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

We listen, learn, and deliver.

Tisento Therapeutics is a Biotechnology Research company specializing in Rare Disease, Mitochondrial Disease, and MELAS. Our lead candidate is zagociguat (formerly CY6463), a Phase 2, first-in-class,

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen November 2026 · 1 capture · latest observed messagingWe listen, learn, and deliver.

    Tisento Therapeutics is a Biotechnology Research company specializing in Rare Disease, Mitochondrial Disease, and MELAS. Our lead candidate is zagociguat (formerly CY6463), a Phase 2, first-in-class,

    This wording observed 13 November 2026.

Companies in the same space

Other funded startups classified under “Early-stage small-molecule and antibody drugs”. This does not mean they compete directly.

Cite this record

StartupHistory, “Tisento Therapeutics” company record, https://startuphistory.org/c/tisentotx.com

Machine-readable: /c/tisentotx.com.json. How changes are found: method.